Medical technology company Getinge (STO:GETI-B) announced on Tuesday the launch of Pulsiocare, an advanced hemodynamic monitoring platform that recently received CE certification.

The state-of-the-art device builds on Getinge's award-winning common user interface, offering a modern and intuitive platform for patient monitoring and hemodynamic assessment. Pulsiocare succeeds the PulsioFlex platform and features a mobile design with a rechargeable battery and responsive touchscreen.

The integration of Getinge's common user interface ensures a familiar and easy-to-navigate experience, reducing the learning curve for healthcare professionals.

Pulsiocare combines Getinge's proven PiCCO and ProAQT technologies into a single monitor. This innovation reflects Getinge's commitment to enhancing medical technology and improving patient care.